PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

CUSIP: 717224109

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM
Total 13F shares
30,417,085
Share change
-1,563,757
Total reported value
$113,148,520
Put/Call ratio
0%
Price per share
$3.72
Number of holders
51
Value change
-$5,321,247
Number of buys
23
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) as of Q2 2021

As of 30 Jun 2021, PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,417,085 shares. The largest 10 holders included NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, Avidity Partners Management LP, RA CAPITAL MANAGEMENT, L.P., Endurant Capital Management LP, VANGUARD GROUP INC, Rock Springs Capital Management LP, Johnson & Johnson Innovation - JJDC, Inc., Altium Capital Management LP, and Candriam Luxembourg S.C.A.. This page lists 51 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.